These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37172332)

  • 1. Understanding the mechanistic potential of plant based phytochemicals in management of postmenopausal osteoporosis.
    Sharma A; Sharma C; Shah OP; Chigurupati S; Ashokan B; Meerasa SS; Rashid S; Behl T; Bungau SG
    Biomed Pharmacother; 2023 Jul; 163():114850. PubMed ID: 37172332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
    Pfeilschifter J
    Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and treatment of osteoporosis: efficacy of combination of hormone replacement therapy with other antiresorptive agents.
    Wimalawansa SJ
    J Clin Densitom; 2000; 3(2):187-201. PubMed ID: 10871912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RANK ligand and denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data.
    Dempster DW; Lambing CL; Kostenuik PJ; Grauer A
    Clin Ther; 2012 Mar; 34(3):521-36. PubMed ID: 22440513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miscellaneous and experimental agents.
    Reginster JY
    Am J Med Sci; 1997 Jan; 313(1):33-40. PubMed ID: 9001164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():45-54. PubMed ID: 8499959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postmenopausal osteoporosis with oestrogen replacement therapy and associated compounds: update on clinical trials since 1995.
    Dören M; Samsioe G
    Hum Reprod Update; 2000; 6(5):419-26. PubMed ID: 11045872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of estrogens in the management of postmenopausal bone loss.
    Gallagher JC
    Rheum Dis Clin North Am; 2001 Feb; 27(1):143-62. PubMed ID: 11285992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Mechanism of Exercise Combined with Natural Extracts to Prevent and Treat Postmenopausal Osteoporosis.
    Zhou T; Gai Z; Gao X; Li L
    J Healthc Eng; 2021; 2021():2852661. PubMed ID: 34956564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New possibilities for diagnosis and treatment of osteoporosis.
    Miller PD
    Int J Fertil Womens Med; 2001; 46(4):215-21. PubMed ID: 11563832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postmenopausal hormonal treatment: conventional hormone replacement therapy or tibolone? Effects on bone].
    Reginster JY
    J Gynecol Obstet Biol Reprod (Paris); 2002 Oct; 31(6):541-9. PubMed ID: 12407324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis: new hope for the future.
    Masi L; Bilezikian JP
    Int J Fertil Womens Med; 1997; 42(4):245-54. PubMed ID: 9309458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates for prevention of postmenopausal osteoporosis.
    Ravn P
    Dan Med Bull; 2002 Feb; 49(1):1-18. PubMed ID: 11894721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.